Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: from the 8K just filed
" Pursuant to the terms of the settlement agreement, TPL has agreed to have PDS allocate to the Company $1,100,000 at the rate of five and ten percent of future distributions due to TPL as a member of PDS; TPL has agreed to increased review and procedures by PDS and the Company on all MSD licensing; the Company has agreed to have PDS pay TPL for certain litigation and reexamination support services at the rate of $172,000 for June 2011, and $86,000 per month thereafter until 60 days after the Markman hearing in the current patent infringement litigation; and the parties have agreed to established guidelines and procedures relating to proposed license arrangements to be entered into by TPL involving the MSD Patents and one or more other patents within TPL’s portfolio that is not an MSD Patent, and a procedure for allocating revenue between the MSD Patents and the non-MSD Patents, if needed."
What is everyone so, excited about ? What was the reason for this filing ? To let PTSC shareholders know they are continuing business as usual. I can't see where PTSC has gained anything, and am not sure why this was released, and the patent exam status was not.
"the parties have agreed to ESTABLISHED GUIDELINES and PROCEEDURES relating to proposed license arrangements to be entered into by TPL involving the MSD Patents and one or more other patents within TPL’s portfolio that is not an MSD Patent, and a procedure for allocating revenue between the MSD Patents and the non-MSD Patents, if needed."
The parties have agreed to ESTABLISHED GUIDELINES and PROCEEDURES so, nothing has changed ? Just wasting more money on lawyers, creating meaningless correspondance to an information starved shareholder base. This is pure fluff !!!
Share
New Message
Please login to post a reply